Autolus Therapeutics plc (AUTL) Net margin 2016–2025
Autolus Therapeutics plc (AUTL) net profit margin by fiscal year — reported net income divided by reported revenue.
-381.4%FY2025 · since FY2016: -1035.5% → -381.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -381.4% | +1799.1 pp |
| FY2024 | -2180.5% | +10091.8 pp |
| FY2023 | -12272.3% | — |
| FY2019 | -4258.9% | -1078.3 pp |
| FY2018 | -3180.6% | -2015.4 pp |
| FY2017 | -1165.2% | -129.7 pp |
| FY2016 | -1035.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice